Warning: foreach() argument must be of type array|object, bool given in /var/www/html/web/app/themes/studypress-core-theme/template-parts/header/mobile-offcanvas.php on line 20

A couple with European ancestry seeks genetic counseling before having children because of a history of cystic fibrosis (CF) in the husband's family. ASO testing for CF reveals that the husband is heterozygous for the \(\Delta 508\) mutation and that the wife is heterozygous for the \(R 117\) mutation. You are the couple's genetic counselor. When consulting with you, they express their conviction that they are not at risk for having an affected child because they each carry different mutations and cannot have a child who is homozygous for either mutation. What would you say to them?

Short Answer

Expert verified
Answer: 25%

Step by step solution

01

Understanding Cystic Fibrosis Mutations

Cystic fibrosis is caused by mutations in the CFTR gene, which codes for a protein that regulates the movement of ions across cell membranes. There are many different mutations in the CFTR gene that can cause cystic fibrosis, but some of the most common mutations are Δ508 and R117. For a child to have cystic fibrosis, they need to inherit two copies of a CFTR gene mutation, one from each parent.
02

Determine the Possible CFTR Gene Combinations in the Offspring

Since the husband carries the Δ508 mutation and the wife carries the R117 mutation, there are four possible combinations of CFTR genes that they could pass on to their offspring: 1. Normal CFTR gene from both parents: No CF 2. Normal CFTR gene from the husband, R117 mutation from the wife: Carrier of R117 mutation 3. Δ508 mutation from the husband, normal CFTR gene from the wife: Carrier of Δ508 mutation 4. Δ508 mutation from the husband, R117 mutation from the wife: Compound heterozygous for CF
03

Explain the Risk of Having a Child with Cystic Fibrosis

The couple's belief that they cannot have a child with cystic fibrosis because they each carry different mutations is incorrect. Although it is true that their child cannot be homozygous for either mutation, they can have a child who is compound heterozygous for both mutations, inheriting one Δ508 mutation from the husband and one R117 mutation from the wife. A compound heterozygous individual can still develop cystic fibrosis, as both CFTR gene copies have mutations that prevent the protein from functioning properly.
04

Calculate the Probability of Having a Child with Cystic Fibrosis

Since there are four possible CFTR gene combinations, and one of them results in a compound heterozygous individual, the probability of them having a child with cystic fibrosis is 1 in 4, or 25%. In conclusion, the couple should be informed that they are at risk for having a child with cystic fibrosis since their child could inherit a combination of the Δ508 and R117 mutations. This would result in a compound heterozygous child with cystic fibrosis with a 25% probability. They should be provided with appropriate resources and support to help them make informed decisions about family planning and prenatal care.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with Vaia!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

CFTR Gene Mutations
Cystic fibrosis (CF) is a genetic disorder primarily affecting the lungs and digestive system. It's caused by mutations in the CFTR gene, which plays a crucial role in regulating the movement of chloride and sodium ions across cell membranes. If the CFTR protein is dysfunctional due to mutations, the transport of these ions is hindered, leading to thick, sticky mucus buildup in various organs.

There are over 1,700 different mutations identified in the CFTR gene that can contribute to cystic fibrosis, but the \(\Delta 508\) mutation is the most common, followed by others like the \(R117H\) mutation. It is important to note that not all mutations have the same effect on the protein's function. Some may completely abolish its function, while others only partially impair it, resulting in various CF severity levels.
Compound Heterozygous
The term 'compound heterozygous' refers to an individual who has inherited two different mutations, one from each parent, which affect the same gene but at different locations. In the context of cystic fibrosis, a compound heterozygous person has two distinct CFTR gene mutations that can lead to the development of the disease.

This differs from being 'homozygous', where two identical gene mutations are inherited. Although compound heterozygotes for CFTR mutations carry different mutations, each can still disrupt the gene's function enough to cause CF symptoms. It's essential to understand that having two different mutations can be just as impactful as having two copies of the same mutation when it comes to diseases like CF.
Genetic Counseling
Genetic counseling is a process that provides support and information to individuals or families who may be at risk for hereditary conditions, such as cystic fibrosis. In the case of the couple concerned about CF in their future children, a genetic counselor would explain the significance of CFTR gene mutations and the implications for their offspring. The counselor would also provide guidance on the range of possible genetic outcomes for their children and discuss the associated risks.

In addition to offering emotional support, genetic counselors can aid in decision-making about family planning, provide information on genetic testing and prenatal diagnosis options, and connect families with resources and support networks. They play a pivotal role in helping individuals understand complex genetic information and its impact on their lives.
Inheritance Patterns
Cystic fibrosis inheritance follows an autosomal recessive pattern. This means that an individual must inherit two copies of the mutated CFTR gene, one from each parent, to exhibit symptoms of the disease. Carriers of CF, who possess only one copy of a mutated gene, typically do not show symptoms.

When both parents are carriers of CFTR mutations, there's a 25% chance of having a child with CF, a 50% chance of having a carrier child, and a 25% chance of having a child with no mutations. In the case of the mentioned couple, with both being carriers of different CFTR mutations, there is a 25% probability that their child will be compound heterozygous for CF. Detailed genetic counseling and understanding these inheritance patterns are crucial for accurate risk assessment and informed family planning.

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

In this chapter, we focused on a number of interesting applications of genetic engineering, genomics, and biotechnology. At the same time, we found many opportunities to consider the methods and reasoning by which much of this information was acquired. From the explanations given in the chapter, what answers would you propose to the following fundamental questions? (a) What experimental evidence confirms that we have introduced a useful gene into a transgenic organism and that it performs as we anticipate? (b) How does a positive ASO test for sickle-cell anemia determine that an individual is homozygous recessive for the mutation that causes sickle-cell anemia? (c) From microarray analysis how do we know what genes are being expressed in a specific tissue? (d) How can we correlate the genome with RNA expression data in a tissue or a single cell? (e) From GWAS how do we know which genes are associated with a particular genetic disorder?

Which of the examples of genetic testing below are prognostic tests? Which are diagnostic? (a) Individual sequencing (personal genomics) identifies a mutation associated with Alzheimer's disease. (b) ASO testing determines that an individual is a carrier for the mutant \(\beta\) -globin allele \(\left(\beta^{S}\right)\) found in sickle-cell anemia. (c) DNA sequencing of a breast tumor reveals mutations in the BRCA1 gene. (d) Genetic testing in a healthy teenager identifies an SNP correlated with autism. (e) An adult diagnosed with Asperger syndrome (AS) has a genetic test that reveals a SNP in the GABRB3 gene that is significantly more common in people with AS than the general population.

Dominant mutations can be categorized according to whether they increase or decrease the overall activity of a gene or gene product. Although a loss-of- function mutation (a mutation that inactivates the gene product) is usually recessive, for some genes, one dose of the normal gene product, encoded by the normal allele, is not sufficient to produce a normal phenotype. In this case, a loss-of-function mutation in the gene will be dominant, and the gene is said to be haploinsufficient. A second category of dominant mutation is the gain- of-function mutation, which results in a new activity or increased activity or expression of a gene or gene product. The gene therapy technique currently being used in clinical trials involves the "addition" to somatic cells of a normal copy of a gene. In other words, a normal copy of the gene is inserted into the genome of the mutant somatic cell, but the mutated copy of the gene is not removed or replaced. Will this strategy work for either of the two aforementioned types of dominant mutations?

Does genetic analysis by ASO testing allow for detection of epigenetic changes that may contribute to a genetic disorder? Explain your answer.

Why are most recombinant human proteins produced in animal or plant hosts instead of bacterial host cells?

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free